Skip to content

Clinical trials

Chronic Urticaria trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Urticaria Country / region: China Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20171
20181
20191
20212
20223
20232
20247
20255
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting8
Not yet recruiting5
Active, not recruiting4
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Hangzhou Highlightll Pharmaceutical Co., Ltd3
Longbio Pharma3
Chengdu Suncadia Medicine Co., Ltd.2
Jemincare2
AlphaMol Science Ltd. (Shanghai)1
Bambusa Therapeutics1
BeOne Medicines1
Beijing InnoCare Pharma Tech Co., Ltd.1
Hong Kong Sanatorium & Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Urticaria32
Urticaria2
Angioedema1
Asthma1
Chronic Inducible Urticaria1
Conjunctivitis, Allergic1
Dermatitis, Atopic1
Pruritus1
Rhinitis, Allergic1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.